Recent Blog Posts

View Post: Genentech, Biogen Idec get FDA request for more information on ...
18 Nov 2009 by AP  
... high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Known commercially as Gleevec, imatinib is a pill that's used to treat some adult leukemias and gastrointestinal cancers. ...
View Blog: Health News - http://blog.taragana.com/health/

---

View Post: Two units of umbilical cord blood 'reduce leukemia recurrence risk ...
14 Nov 2009 by ANI  
Eighty-eight patients had acute lymphoblastic leukaemia (ALL) and 89 had acute myeloid leukaemia (AML). “Our analysis showed that patients in first or second remission from the leukaemia had a significantly lower likelihood of leukaemia recurrence if they were transplanted with two ... Washington, Nov 6 (ANI): Scientists from Fred Hutchinson Cancer Research Centre have come up with a novel treatment that would improve survival rates of leukemia and pre-leukemia patients. ...
View Blog: Trak.in News» Trak.in News

---

View Post: acute lymphoblastic leukemia causes - Health Resources - Health ...
1 Oct 2009 by Tiny  
Leukemia Home Page - National Cancer Institute Clinical Trials to Treat Adult Acute Lymphoblastic Leukemia . Clinical Trials to Treat Adult Acute Myeloid Leukemia. More. Prevention, Genetics, Causes . ->. acute lymphoblastic leukemia ...
View Blog: Health Resources - http://www.health-res.com/

---

View Post: I Think I Might Have Leukemia But My Family Won't Take Me ...
19 hours ago by admin  
Cancer therapy. Children and adults who've had certain types of chemotherapy and radiation therapy or treatment for other kinds of cancer may have a small, but greater, risk of developing acute lymphocytic leukemia than does the general .... Additionally, although treatment for adult and childhood acute lymphocytic leukemia is very successful, it can be a long road. Treatment typically lasts two and a half to three and a half years, although the first three to six months ...
View Blog: Leukemia Blog - http://www.content101.cn/leukemia/

---

View Post: Leukemia Clinical Trial: Combination Chemotherapy in Treating ...
29 Oct 2009
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia. RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Two Units of Cord Blood Reduces Likelihood of Recurrence of ...
16 Nov 2009 by Cord Blood  
A recent study conducted at the Masonic Cancer Center, University of Minnesota discovered that transplantation of 2 units of cord blood significantly reduces the likelihood of recurrence of leukemia. ... Eighty-eight patients were treated for acute lymphoblastic leukemia (ALL) and 89 were treated for acute myeloid leukemia (AML). The analysis demonstrated that that patients in first or second remission from leukemia had a significantly lower likelihood of recurrence if ...
View Blog: Cord Blood Bank Cord Blood Banking - http://cordbloodcordbank.com/

---

View Post: U of M researchers find 2 units of umbilical cord blood reduce ...
13 Nov 2009 by BJS  
PAUL (November 11, 2009) -- A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning ... "Given that adult patients were more likely to receive two UCB units and that they tend to have more aggressive leukemia, we think that the lower relapse rates with two UCB units is remarkable," says Verneris. ...
View Blog: Science Blog - Science news straight from... - http://www.scienceblog.com/cms/frontpage1

---

View Post: Young Adults With Acute Lymphoblastic Leukemia Have an Excellent ...
29 Oct 2009 by Nachman, La, Hunger, Heerema, Gaynon, Hastings,...  
Purpose Patients 16 to 21 years of age with acute lymphoblastic leukemia (ALL) have an inferior outcome compared with younger children, leading some medical oncologists to advocate allogeneic stem-cell transplantation in first remission for ... Conclusion Young adult patients with ALL showing a rapid response to induction chemotherapy benefit from early intensive postinduction therapy but do not benefit from a second interim maintenance and delayed intensification phase. ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/

---

View Post: Gene polymorphisms in folate metabolizing enzymes in adult acute ...
30 Sep 2009 by Ongaro, A., De Mattei, M., Della Porta,...  
Design and Methods: The aim of this study was to investigate the influence of polymorphisms for folate metabolizing enzymes with respect to toxicity and survival in adult patients with acute lymphoblastic leukemia treated with ...
View Blog: Haematologica current issue - http://www.haematologica.org/

---

View Post: Orphan drug designation granted to voreloxin for acute myeloid ...
5 Nov 2009
Sunesis Pharmaceuticals was granted orphan drug designation by the FDA for its drug candidate, voreloxin for the treatment of acute myeloid leukemia (AML). ... urate oxidase enzyme, has been approved for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid. ...
View Blog: Latest articles from MPR - http://www.empr.com/

---